OraSure Technologies, Inc. (OSUR) Stake Increased by SECOR Capital Advisors LP
SECOR Capital Advisors LP boosted its stake in OraSure Technologies, Inc. (NASDAQ:OSUR) by 99.0% during the third quarter, Holdings Channel reports. The institutional investor owned 99,424 shares of the company’s stock after buying an additional 49,466 shares during the period. SECOR Capital Advisors LP owned about 0.18% of OraSure Technologies worth $792,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Dynamic Technology Lab Private Ltd increased its position in OraSure Technologies by 245.7% in the second quarter. Dynamic Technology Lab Private Ltd now owns 37,177 shares of the company’s stock valued at $220,000 after buying an additional 26,424 shares during the period. Vanguard Group Inc. increased its position in OraSure Technologies by 21.7% in the second quarter. Vanguard Group Inc. now owns 2,884,015 shares of the company’s stock valued at $17,045,000 after buying an additional 515,201 shares during the period. Prudential Financial Inc. bought a new position in OraSure Technologies during the second quarter valued at approximately $244,000. Dimensional Fund Advisors LP increased its position in OraSure Technologies by 44.1% in the second quarter. Dimensional Fund Advisors LP now owns 1,582,869 shares of the company’s stock valued at $9,357,000 after buying an additional 484,702 shares during the period. Finally, Systematic Financial Management LP increased its position in OraSure Technologies by 4.1% in the second quarter. Systematic Financial Management LP now owns 685,576 shares of the company’s stock valued at $4,051,000 after buying an additional 27,235 shares during the period. 81.91% of the stock is owned by institutional investors.
Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) traded up 1.26% on Friday, hitting $8.86. 242,569 shares of the company were exchanged. The firm’s 50-day moving average is $8.81 and its 200-day moving average is $7.80. OraSure Technologies, Inc. has a 52-week low of $5.09 and a 52-week high of $9.53. The stock has a market capitalization of $493.77 million, a PE ratio of 29.53 and a beta of 1.55.
OraSure Technologies (NASDAQ:OSUR) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $0.11 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.07 by $0.04. OraSure Technologies had a net margin of 13.70% and a return on equity of 10.27%. The company had revenue of $32.25 million for the quarter, compared to analysts’ expectations of $31.45 million. During the same period last year, the company earned $0.03 EPS. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Equities research analysts predict that OraSure Technologies, Inc. will post $0.28 earnings per share for the current year.
Several research firms have commented on OSUR. Zacks Investment Research raised shares of OraSure Technologies from a “hold” rating to a “buy” rating and set a $9.75 price objective for the company in a report on Wednesday, January 4th. CL King began coverage on shares of OraSure Technologies in a report on Tuesday, December 20th. They set a “buy” rating and a $11.00 price objective for the company. Canaccord Genuity set a $10.00 price objective on shares of OraSure Technologies and gave the company a “buy” rating in a report on Monday, November 28th. Finally, BTIG Research downgraded shares of OraSure Technologies from a “buy” rating to a “neutral” rating and set a $8.00 price objective for the company. in a report on Monday, September 19th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $9.25.
In other OraSure Technologies news, SVP Mark L. Kuna sold 3,000 shares of the firm’s stock in a transaction dated Friday, December 9th. The shares were sold at an average price of $9.03, for a total transaction of $27,090.00. Following the sale, the senior vice president now directly owns 75,965 shares of the company’s stock, valued at approximately $685,963.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Douglas A. Michels sold 30,893 shares of the firm’s stock in a transaction dated Wednesday, November 23rd. The stock was sold at an average price of $9.02, for a total transaction of $278,654.86. Following the sale, the chief executive officer now directly owns 731,898 shares in the company, valued at $6,601,719.96. The disclosure for this sale can be found here. Company insiders own 7.80% of the company’s stock.
About OraSure Technologies
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Want to see what other hedge funds are holding OSUR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for OraSure Technologies, Inc. (NASDAQ:OSUR).
Receive News & Ratings for OraSure Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.